While sleep apnea is considered common in adults ... their key symptoms, and how a doctor might diagnose and treat them. The two most commonly recognized types of sleep apnea are obstructive ...

If you experience these symptoms, consider speaking with ... Home sleep apnea tests can also help identify obstructive sleep apnea in adults suspected of having moderate to severe obstructive ...

This is also called Obstructive ... older adults with medical conditions like sleep apnoea can be challenging. However, they can show support by being aware of the signs and symptoms of sleep ...

Many major maladies have been linked to disturbed slumber caused by sleep apnea, high blood pressure, heart problems a ...

Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in ...

Obstructive sleep apnea (OSA) syndrome is a highly prevalent disorder in the general population, as demonstrated by studies in the USA and Europe that have established the prevalence in the middle ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

“This is a major step forward for patients with obstructive sleep apnea ... adults with obesity. Nearly half of the clinical trial patients saw such improvements that they no longer had symptoms ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Patients with significant comorbidities or other suspected sleep disorders must be excluded; these cases call for a PSG. In a case of clinical suspicion and a negative home test, OSA cannot be ...

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...